Structural biology of the tumor suppressor p53 and cancer-associated mutants

被引:83
作者
Joerger, Andreas C. [1 ]
Fersht, Alan R. [1 ]
机构
[1] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England
来源
ADVANCES IN CANCER RESEARCH, VOL 97 | 2007年 / 97卷
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0065-230X(06)97001-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor suppressor protein p53 is a transcription factor that plays a key role in the prevention of cancer development. In response to oncogenic or other stresses, the p53 protein is activated and regulates the expression of a variety of target genes, resulting in cell cycle arrest, senescence, or apoptosis. Mutation of the p53 gene is the most common genetic alteration in human cancer, affecting more than 50% of human tumors. Most of these mutations inactivate the DNA-binding domain of the protein. In this chapter, we describe the structure of the wild-type p53 protein and present structural and functional data that provide the molecular basis for understanding the effects of common cancer mutations. Further, we assess novel therapeutic strategies that aim to rescue the function of p53 cancer mutants. (c) 2007 Elsevier Inc.
引用
收藏
页码:1 / +
页数:26
相关论文
共 84 条
[71]   Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2) [J].
Tidow, Henning ;
Veprintsev, Dmitry B. ;
Freund, Stefan M. V. ;
Fersht, Alan R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (43) :32526-32533
[72]   Core domain interactions in full-length p53 in solution [J].
Veprintsev, DB ;
Freund, SMV ;
Andreeva, A ;
Rutledge, SE ;
Tidow, H ;
Cañadillas, JMP ;
Blair, CM ;
Fersht, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (07) :2115-2119
[73]   Surfing the p53 network [J].
Vogelstein, B ;
Lane, D ;
Levine, AJ .
NATURE, 2000, 408 (6810) :307-310
[74]   Live or let die: The cell's response to p53 [J].
Vousden, KH ;
Lu, X .
NATURE REVIEWS CANCER, 2002, 2 (08) :594-604
[75]   Identification of a novel p53 functional domain that is necessary for efficient growth suppression [J].
Walker, KK ;
Levine, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) :15335-15340
[76]   Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding [J].
Wang, WG ;
Takimoto, R ;
Rastinejad, F ;
El-Deiry, WS .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (06) :2171-2181
[77]   Cooperative binding of tetrameric p53 to DNA [J].
Weinberg, RL ;
Veprintsev, DB ;
Fersht, AR .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 341 (05) :1145-1159
[78]   Regulation of DNA binding of p53 by its C-terminal domain [J].
Weinberg, RL ;
Freund, SMV ;
Veprintsev, DB ;
Bycroft, M ;
Fersht, AR .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 342 (03) :801-811
[79]   Structure-based rescue of common tumor-derived p53 mutants [J].
Wieczorek, AM ;
Waterman, JLF ;
Waterman, MJF ;
Halazonetis, TD .
NATURE MEDICINE, 1996, 2 (10) :1143-1146
[80]   Strategies for therapeutic targeting of the p53 pathway in cancer [J].
Wiman, K. G. .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (06) :921-926